Key result
Zero-fluoroscopy ablation in pregnant women achieves ~100% efficacy with minimal complications and no recurrences.
Why the study?
Data on perinatal outcomes and the results of zero-fluoroscopy catheter ablation in pregnant patients with arrhythmias are limited.
Does zero-fluoroscopy catheter ablation safely prevent arrhythmia recurrence in pregnant women with arrhythmias?
Observational (n=48)
Does zero-fluoroscopy catheter ablation safely prevent arrhythmia recurrence in pregnant women with arrhythmias?
Zero-fluoroscopy catheter ablation is highly effective and safe for pregnant women with arrhythmias, demonstrating no recurrences at 24 months and benign perinatal outcomes.
May support fluoroless ablation feasibility in pregnancy; leaves open need for larger prospective trials before wider adoption.
Funding Acknowledgements Type of funding sources: None. Background Incidences of rhythm disturbance in pregnant are commonly seen. Catheter ablation of arrhythmias has been shown to be effective and safe. Data on perinatal outcomes and results of zero-fluoroscopy catheter ablation in pregnant patients is limited. Purpose the aim of our study is to observe long-term results and perinatal outcomes in pregnant women with arrhythmias, treated by zero-fluoroscopy catheter ablation method. Methods There were 48 pregnant women, who underwent zero-fluoroscopy catheter ablation (Mean age of pregnant was 25.7±4.3 years, mean gestation age 24.1 ±3.2 weeks). Procedure-related complications, perinatal outcomes and arrhythmia recurrence were documented during 24 months follow-up. Results The most common arrhythmias were atrioventricular nodal reentrant tachycardia (n=21; 43.75%). This was followed by Wolff–Parkinson–White syndrome (n=15; 31.25%). Combination of accessory pathways with slow conduction ways were found in 3 cases (6.25%). In six cases were ablation due to frequent premature ventricular contraction (12.5%). Ventricular tachycardia was rare during pregnancy (n=3; 6.25%). Zero-fluoroscopy catheter ablation was performed under the guidance of CARTO (n=21; 43.75%) and Ensite Precision systems (n=27; 56.25%). The median procedural time was 71±15 minutes. Interventions were effective in all cases (100%). Procedural complication was in one patient (2.1%), who developed an ileofemoral thrombosis. Pregnancy course after ablation procedure was benign in all patients. Perinatal outcomes: spontaneus vaginal delivery was in the majority of cases (n=36; 75%). Twelve pregnancies (25%) were delivered by cesarean section due to obstetric indicators. Intrapartum hemorrhage was 335.2±228.92 ml. Two women had placental abraption and preeclampsia (4.2%). Maternal adverse cardiac events were none declared. There were 48 live births (in all cases). Fetal birth weight was 3324.7±684.4 grams, 5 minute Apgar was 8.4±1.3. There were no maternal and fetal mortality. At 24 months there were no arrhythmia recurrence. Conclusions Zero-fluoroscopy catheter ablation method is safe and effective in pregnant women with arrhythmias. Pregnancy course and outcomes after this procedure is bening in the majority of cases.
No takes yet. Share an insight, caveat, or question.
Abdrakhmanov et al. (2023) conducted an observational in Arrhythmias in pregnancy (n=48). Zero-fluoroscopy catheter ablation was evaluated on Arrhythmia recurrence at 24 months. Zero-fluoroscopy catheter ablation in pregnant women with arrhythmias was 100% effective with a 2.1% complication rate and no arrhythmia recurrence at 24 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: